On July 30th, Barclays raised the target price of Abbott Laboratories from $140 to $143 and maintained a "shareholding" rating.
巴克莱上调雅培目标价至143美元
Barclays raised the target price of Abbott Laboratories to $143.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.